
Calcivis
Biotechnology-driven imaging system for early detection and prevention of tooth demineralization.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
investor | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
investor investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor investor investor | €0.0 | round | |
investor investor investor | €0.0 | round | |
investor investor | €0.0 | round | |
investor investor investor | €0.0 Valuation: €0.0 100.1x EV/Revenue -17.4x EV/EBITDA | round | |
* | £5.0m | Early VC | |
Total Funding | 000k |
GBP | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | (30 %) | (98 %) | 10 % | (81 %) | 8719 % | (87 %) | (85 %) |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | (221 %) | (22560 %) | (24926 %) | (52609 %) | (575 %) | (5019 %) | - |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | (241 %) | (22130 %) | (26031 %) | (59615 %) | (553 %) | (4825 %) | (51480 %) |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
R&D % of revenue | 129 % | 3145 % | 1249 % | 18744 % | - | - | - |
Source: Company filings or news article
Related Content
CALCIVIS is a pioneering company in the field of preventive dentistry, offering an innovative solution to help dental clinicians detect and manage active tooth demineralization. The company's flagship product, the Calcivis Imaging System, is a state-of-the-art device that resembles a standard intraoral camera. This system allows dentists and their patients to see calcium ions being released from a demineralizing tooth surface in real-time. This visualization is made possible through the use of a recombinant bioluminescent photoprotein, which reacts with free calcium ions to produce light.
The primary market for CALCIVIS includes dental clinics and practitioners who are focused on preventive care. By enabling early detection of tooth decay, the Calcivis Imaging System helps clinicians intervene before cavities develop, potentially reversing the decay process and avoiding the need for more invasive treatments like drilling and filling.
CALCIVIS operates within the dental healthcare market, specifically targeting issues related to caries diagnosis and preventive management. The company's business model revolves around selling the Calcivis Imaging System to dental practices, along with providing ongoing support and maintenance services. Revenue is generated through the sale of the imaging systems, as well as through service contracts and potential future updates or enhancements to the technology.
In summary, CALCIVIS offers a groundbreaking technology that empowers dental professionals to adopt a minimal intervention approach to dentistry. By providing visual evidence of active tooth decay, the system not only aids in accurate diagnosis but also encourages patient compliance with preventive measures.
Keywords: preventive dentistry, tooth demineralization, dental clinicians, imaging technology, early decay detection, biotechnology, dental healthcare, caries diagnosis, minimal intervention, patient compliance.